Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: A systematic review and meta-analysis of randomized, double-blind and sham-controlled trials

Psychological Medicine

Volumn 44, Issue 2, 2014, Pages 225-239

  Berlim, M T ^a   Van Den Eynde, F ^a   Tovar Perdomo, S ^a   Daskalakis, Z J ^b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acceptability; Efficacy; Major depression; Meta analysis; Repetitive transcranial magnetic stimulation

Indexed keywords

DOUBLE BLIND PROCEDURE; HUMAN; MAJOR DEPRESSION; META ANALYSIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; STANDARD; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84890661794     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713000512     Document Type: Article

References (94)

1. Allan CL, Herrmann LL, Ebmeier KP (2011). Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology 64, 163-169.
2. Anderson IM, Delvai NA, Ashim B, Ashim S, Lewin C, Singh V, Sturman D, Strickland PL (2007). Adjunctive fast repetitive transcranial magnetic stimulation in depression. British Journal of Psychiatry 190, 533-534.
3. APA (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). American Psychiatric Association: Washington, DC.
4. Arns M, Drinkenburg WH, Fitzgerald PB, Kenemans JL (2012). Neurophysiological predictors of non-response to rTMS in depression. Brain Stimulation 5, 569-576.
5. Avery DH, Holtzheimer PE 3rd, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P (2006). A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biological Psychiatry 59, 187-194.
6. Bakim B, Uzun U, Karamustafalioglu K, Ozcelik B, Alpak G, Tankaya O, Ceylan Y (in press). Combination of fast repetitive transcranial magnetic stimulation with antidepressant treatment in medication-resistant depression. Bulletin of Clinical Psychopharmacology.
7. Berlim MT, Broadbent H, Van den Eynde F (2013). Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis. International Journal of Neuropsychopharmacology. Published online 11 February 2013. doi:10.1017/S1461145712001691.
8. Berlim MT, Fleck MP (2003). 'Quality of life': a brand new concept for research and practice in psychiatry. Revista Brasileira de Psiquiatria 25, 249-252.
9. Berlim MT, Fleck MP, Turecki G (2008). Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Annals of Medicine 40, 149-159.
10. Berlim MT, Turecki G (2007). What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. European Neuropsychopharmacology 17, 696-707.
11. Berman RM, Narasimhan M, Sanacora G, Miano AP, Hoffman RE, Hu XS, Charney DS, Boutros NN (2000). A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biological Psychiatry 47, 332-337.
12. Blumberger DM, Mulsant BH, Fitzgerald PB, Rajji TK, Ravindran AV, Young LT, Levinson AJ, Daskalakis ZJ (2012). A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World Journal of Biological Psychiatry 13, 423-435.
13. Borckardt JJ, Walker J, Branham RK, Rydin-Gray S, Hunter C, Beeson H, Reeves ST, Madan A, Sackeim H, George MS (2008). Development and evaluation of a portable sham transcranial magnetic stimulation system. Brain Stimulation 1, 52-59.
14. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009). Introduction to Meta-Analysis. Wiley & Sons Ltd: Chichester.
15. Boutros NN, Gueorguieva R, Hoffman RE, Oren DA, Feingold A, Berman RM (2002). Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression. Psychiatry Research 113, 245-254.
16. Burt T, Lisanby SH, Sackeim HA (2002). Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. International Journal of Neuropsychopharmacology 5, 73-103.
17. Chistyakov AV, Rubicsek O, Kaplan B, Zaaroor M, Klein E (2010). Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. International Journal of Neuropsychopharmacology 13, 387-393.
18. Citrome L (2011). Number needed to treat: what it is and what it isn't, and why every clinician should know how to calculate it. Journal of Clinical Psychiatry 72, 412-413.
19. Cooper H, Hedges LV, Valentine JC (2009). The Handbook of Research Synthesis and Meta-Analysis. Russell Sage Foundation Publications: New York.
20. Couturier JL (2005). Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. Journal of Psychiatry and Neuroscience 30, 83-90.
21. Deeks JJ (2002). Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 21, 1575-1600.
22. DerSimonian R, Kacker R (2007). Random-effects model for meta-analysis of clinical trials: an update. Contemporary Clinical Trials 28, 105-114.
23. Downar J, Daskalakis ZJ (2012). New targets for rTMS in depression: a review of convergent evidence. Brain Stimulation. Published online 7 September 2012. doi:10.1016/j.brs.2012.08.006.
24. Duval S, Tweedie R (2000). Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455-463.
25. Ebmeier KP, Donaghey C, Steele JD (2006). Recent developments and current controversies in depression. Lancet 367, 153-167.
26. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315, 629-634.
27. Egger M, Smith GD, Altman D (eds.) (2001). Systematic Reviews on Health Care: Meta-Analysis in Context. BMJ Publishing Group: London.
28. Fergusson D, Aaron SD, Guyatt G, Hebert P (2002). Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. British Medical Journal 325, 652-654.
29. Fitzgerald PB (2010). Repetitive transcranial magnetic stimulation treatment for depression: lots of promise but still lots of questions. Brain Stimulation 2, 185-187.
30. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J (2003). Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Archives of General Psychiatry 60, 1002-1008.
31. Fitzgerald PB, Hoy KE, Herring SE, McQueen S, Peachey AV, Segrave RA, Maller J, Hall P, Daskalakis ZJ (2012). A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. Journal of Affective Disorders 139, 193-198.
32. Fitzgerald PB, Hoy KE, McQueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ (2009). A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 34, 1255-1262.
33. Fritz CO, Morris PE, Richler JJ (2012). Effect size estimates: current use, calculations, and interpretation. Journal of Experimental Psychology General 141, 2-18.
34. Garcia-Toro M, Mayol A, Arnillas H, Capllonch I, Ibarra O, Crespi M, Mico J, Lafau O, Lafuente L (2001). Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. Journal of Affective Disorders 64, 271-275.
35. George MS, Aston-Jones G (2010). Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology 35, 301-316.
36. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA (2010). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry 67, 507-516.
37. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, Arana GW, Risch SC, Ballenger JC (2000). A controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry 48, 962-970.
38. George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, Greenberg BD, Hallett M, Post RM (1997). Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. American Journal of Psychiatry 154, 1752-1756.
39. Gross M, Nakamura L, Pascual-Leone A, Fregni F (2007). Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatrica Scandinavica 116, 165-173.
40. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
41. Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, Haynor D, George MS, Nahas Z (2009). More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biological Psychiatry 66, 509-515.
42. Hernández-Ribas R, Deus J, Pujol J, Segalàs C, Vallejo J, Menchón JM, Cardoner N, Soriano-Mas C (2013). Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation (rTMS) in major depression. Brain Stimulation 6, 54-61.
43. Herrmann LL, Ebmeier KP (2006). Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. Journal of Clinical Psychiatry 67, 1870-1876.
44. Higgins JPT, Green S (eds) (2008). Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons Ltd: Chichester.
45. Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM (2010). Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depression and Anxiety 27, 960-963.
46. Holtzheimer 3rd PE, Russo J, Claypoole KH, Roy-Byrne P, Avery DH (2004). Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depression and Anxiety 19, 24-30.
47. Hoppner J, Schulz M, Irmisch G, Mau R, Schlafke D, Richter J (2003). Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. European Archives of Psychiatry and Clinical Neuroscience 253, 103-109.
48. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF (2010). Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation 3, 187-199.
49. Keller MB (2004). Remission versus response: the new gold standard of antidepressant care. Journal of Clinical Psychiatry 65 (Suppl. 4), 53-59.
50. Koerselman F, Laman DM, van Duijn H, van Duijn MA, Willems MA (2004). A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression. Journal of Clinical Psychiatry 65, 1323-1328.
51. Kozel FA, George MS (2002). Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. Journal of Psychiatric Practice 8, 270-275.
52. Lam RW, Chan P, Wilkins-Ho M, Yatham LN (2008). Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Canadian Journal of Psychiatry 53, 621-631.
53. Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. Journal of Affective Disorders 117 (Suppl. 1), S26-S43.
54. Levkovitz Y, Harel EV, Roth Y, Braw Y, Most D, Katz LN, Sheer A, Gersner R, Zangen A (2010). Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimulation 4, 188-200.
55. Loo CK, Mitchell PB, McFarquhar TF, Malhi GS, Sachdev PS (2007). A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression. Psychological Medicine 37, 341-349.
56. Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, Gironell A (2002). Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews. Issue 4. Art. No.: CD003493. doi:10.1002/14651858.CD003493.
57. Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J (2003). Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. British Journal of Psychiatry 182, 480-491.
58. Mathers CD, Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3, e442.
59. McNamara B, Ray JL, Arthurs OJ, Boniface S (2001). Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychological Medicine 31, 1141-1146.
60. Mogg A, Pluck G, Eranti SV, Landau S, Purvis R, Brown RG, Curtis V, Howard R, Philpot M, McLoughlin DM (2008). A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychological Medicine 38, 323-333.
61. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG (2010). CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology 63, e1-e37.
62. Moher D, Liberati A, Tetzlaff J, Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535.
63. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389.
64. Mosimann UP, Schmitt W, Greenberg BD, Kosel M, Muri RM, Berkhoff M, Hess CW, Fisch HU, Schlaepfer TE (2004). Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Research 126, 123-133.
65. Nahas Z, Kozel FA, Li X, Anderson B, George MS (2003). Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disorders 5, 40-47.
66. Nelson JC, Papakostas GI (2009). Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. American Journal of Psychiatry 166, 980-991.
67. Nierenberg AA, DeCecco LM (2001). Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. Journal of Clinical Psychiatry 62 (Suppl. 16), 5-9.
68. Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ (2006). A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STARD report. American Journal of Psychiatry 163, 1519-1530.
69. O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological Psychiatry 62, 1208-1216.
70. Padberg F, Zwanzger P, Keck ME, Kathmann N, Mikhaiel P, Ella R, Rupprecht P, Thoma H, Hampel H, Toschi N, Moller HJ (2002). Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology 27, 638-645.
71. Palliere-Martinot ML, Galinowski A, Ringuenet D, Gallarda T, Lefaucheur JP, Bellivier F, Picq C, Bruguiere P, Mangin JF, Riviere D, Willer JC, Fallisard B, Leboyer M, Olie JP, Artiges E, Martinot JL (2010). Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)] F-fluorodeoxyglucose PET and MRI study. International Journal of Neuropsychopharmacology 13, 45-59.
72. Ridding MC, Rothwell JC (2007). Is there a future for therapeutic use of transcranial magnetic stimulation? Nature Reviews in Neuroscience 8, 559-567.
73. Riley RD, Higgins JP, Deeks JJ (2011). Interpretation of random effects meta-analyses. BMJ 342, d549.
74. Rosa MA, Lisanby SH (2012). Somatic treatments for mood disorders. Neuropsychopharmacology 37, 102-116.
75. Rosenthal R (1979). The file drawer problem and tolerance for null results. Psychological Bulletin 86, 638-641.
76. Rossi S, Hallett M, Rossini PM, Pascual-Leone A (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology 120, 2008-2039.
77. Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E (2005). Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial. Psychiatry Research 137, 1-10.
78. Ruohonen J, Karhu J (2010). Navigated transcranial magnetic stimulation. Neurophysiologie Clinique 40, 7-17.
79. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1841-1853.
80. Rusjan PM, Barr MS, Farzan F, Arenovich T, Maller JJ, Fitzgerald PB, Daskalakis ZJ (2010). Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Human Brain Mapping 31, 1643-1652.
81. Sandrini M, Umilta C, Rusconi E (2011). The use of transcranial magnetic stimulation in cognitive neuroscience: a new synthesis of methodological issues. Neuroscience and Biobehavioral Reviews 35, 516-536.
82. Schonfeldt-Lecuona C, Lefaucheur JP, Cardenas-Morales L, Wolf RC, Kammer T, Herwig U (2010). The value of neuronavigated rTMS for the treatment of depression. Neurophysiologie Clinique 40, 37-43.
83. Schutter DJ (2009). Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychological Medicine 39, 65-75.
84. Schutter DJ (2010). Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychological Medicine 40, 1789-1795.
85. Slotema CW, Blom JD, Hoek HW, Sommer IE (2010). Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. Journal of Clinical Psychiatry 71, 873-884.
86. Stern WM, Tormos JM, Press DZ, Pearlman C, Pascual-Leone A (2007). Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. Journal of Neuropsychiatry and Clinical Neuroscience 19, 179-186.
87. Su T, Huang C, Wei I (2005). Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients. Journal of Clinical Psychiatry 66, 930-937.
88. Triggs WJ, Ricciuti N, Ward HE, Cheng J, Bowers D, Goodman WK, Kluger BM, Nadeau SE (2010). Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Psychiatry Research 15, 467-474.
89. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice. American Journal of Psychiatry 163, 28-40.
90. Undurraga J, Baldessarini RJ (2012). Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 37, 851-864.
91. Wassermann EM, Zimmermann T (2012). Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacological Therapy 133, 98-107.
92. World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.
93. Zhang XH, Wang LW, Wang JJ, Liu Q, Fan Y (2011). Adjunctive treatment with transcranial magnetic stimulation in treatment resistant depression: a randomized, double-blind, sham controlled study. Shanghai Archives of Psychiatry 23, 17-24.
94. Zheng H, Zhang L, Li L, Liu P, Gao J, Liu X, Zou J, Zhang Y, Liu J, Zhang Z, Li Z, Men W (2010). High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression. Progress in Neuropsychopharmacology and Biological Psychiatry 34, 1189-1195.